| 标题 |
Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy |
| 网址 | |
| DOI |
10.1136/annrheumdis-2013-204137
doi
|
| 其它 |
期刊:Ann Rheum Dis 作者:Nishina N, Kikuchi J, Hashizume M, Yoshimoto K, Kameda H, Takeuchi T 出版日期:2013-12-13 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)